Cargando…
Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival
PURPOSE: The purpose of this study is to assess the correlation between metabolic response with fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and pathological response in patients with locally advanced esophageal cancer treated with neoadjuvant chemoradiotherapy an...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348503/ https://www.ncbi.nlm.nih.gov/pubmed/37456192 http://dx.doi.org/10.4103/ijnm.ijnm_12_22 |
_version_ | 1785073678729347072 |
---|---|
author | Robles Barba, Javier J. Llobera, Aida Sabaté Cenzano, Cristina Gámez Martin Marcuartu, Juan J. Martínez, Natalia Romero Paules Villar, Maria J. Larrañaga, Carla Bettonica Inglada, Anna Boladeras Campos, Mariona Calvo Pous, Albert Font Guzmán, Maica Galán Romera, Montserrat Cortés |
author_facet | Robles Barba, Javier J. Llobera, Aida Sabaté Cenzano, Cristina Gámez Martin Marcuartu, Juan J. Martínez, Natalia Romero Paules Villar, Maria J. Larrañaga, Carla Bettonica Inglada, Anna Boladeras Campos, Mariona Calvo Pous, Albert Font Guzmán, Maica Galán Romera, Montserrat Cortés |
author_sort | Robles Barba, Javier J. |
collection | PubMed |
description | PURPOSE: The purpose of this study is to assess the correlation between metabolic response with fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and pathological response in patients with locally advanced esophageal cancer treated with neoadjuvant chemoradiotherapy and to study FDG-PET parameters for the prediction of pathological response and outcome. METHODS: Twenty-five patients with locally advanced esophageal cancer underwent two FDG-PET/CT scans for initial staging and after neoadjuvant chemoradiotherapy. FDG uptake in the primary tumor was calculated in both scans (SUVmax, SULpeak, and TLG). Metabolic response was assessed according to the reduction of PET parameters: complete response (mCR = 100%), partial response (mPR ≥50%), and no response (mNR ≤50%). Pathological response was also classified as complete (pCR), partial (pPR), or no response (pNR). Patients were followed up (range, 8–99 months) determining free-disease interval (FDI) and overall survival (OS). RESULTS: Two patients were excluded due to exitus for nonesophageal-related causes. The metabolic response was observed in 18/23 remaining patients (3mCR, 15 mPR), of which 12/18 patients showed a pathological response (3 pCR, 9 pPR). A major discrepancy was observed in 2 mNR patients who achieved pPR. FDI and OS were longer in patients with metabolic response than nonresponders, but no statistical difference was found. No significant correlation was found between PET parameters and pathological response, FDI, and OS. CONCLUSIONS: FDG-PET/CT is a useful technique to assess response to neoadjuvant chemoradiotherapy in esophageal cancer. Although in this preliminary study, no correlation between metabolic and pathologic response was found and no statistical differences between responders and nonresponders were observed, a tendency of longer FDI and OS was apparently found in responders patients. |
format | Online Article Text |
id | pubmed-10348503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-103485032023-07-15 Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival Robles Barba, Javier J. Llobera, Aida Sabaté Cenzano, Cristina Gámez Martin Marcuartu, Juan J. Martínez, Natalia Romero Paules Villar, Maria J. Larrañaga, Carla Bettonica Inglada, Anna Boladeras Campos, Mariona Calvo Pous, Albert Font Guzmán, Maica Galán Romera, Montserrat Cortés Indian J Nucl Med Original Article PURPOSE: The purpose of this study is to assess the correlation between metabolic response with fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and pathological response in patients with locally advanced esophageal cancer treated with neoadjuvant chemoradiotherapy and to study FDG-PET parameters for the prediction of pathological response and outcome. METHODS: Twenty-five patients with locally advanced esophageal cancer underwent two FDG-PET/CT scans for initial staging and after neoadjuvant chemoradiotherapy. FDG uptake in the primary tumor was calculated in both scans (SUVmax, SULpeak, and TLG). Metabolic response was assessed according to the reduction of PET parameters: complete response (mCR = 100%), partial response (mPR ≥50%), and no response (mNR ≤50%). Pathological response was also classified as complete (pCR), partial (pPR), or no response (pNR). Patients were followed up (range, 8–99 months) determining free-disease interval (FDI) and overall survival (OS). RESULTS: Two patients were excluded due to exitus for nonesophageal-related causes. The metabolic response was observed in 18/23 remaining patients (3mCR, 15 mPR), of which 12/18 patients showed a pathological response (3 pCR, 9 pPR). A major discrepancy was observed in 2 mNR patients who achieved pPR. FDI and OS were longer in patients with metabolic response than nonresponders, but no statistical difference was found. No significant correlation was found between PET parameters and pathological response, FDI, and OS. CONCLUSIONS: FDG-PET/CT is a useful technique to assess response to neoadjuvant chemoradiotherapy in esophageal cancer. Although in this preliminary study, no correlation between metabolic and pathologic response was found and no statistical differences between responders and nonresponders were observed, a tendency of longer FDI and OS was apparently found in responders patients. Wolters Kluwer - Medknow 2023 2023-06-08 /pmc/articles/PMC10348503/ /pubmed/37456192 http://dx.doi.org/10.4103/ijnm.ijnm_12_22 Text en Copyright: © 2023 Indian Journal of Nuclear Medicine https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Robles Barba, Javier J. Llobera, Aida Sabaté Cenzano, Cristina Gámez Martin Marcuartu, Juan J. Martínez, Natalia Romero Paules Villar, Maria J. Larrañaga, Carla Bettonica Inglada, Anna Boladeras Campos, Mariona Calvo Pous, Albert Font Guzmán, Maica Galán Romera, Montserrat Cortés Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival |
title | Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival |
title_full | Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival |
title_fullStr | Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival |
title_full_unstemmed | Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival |
title_short | Role of (F-18) Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Prediction of Response to Neoadjuvant Therapy in Esophageal Cancer: Correlation with Pathological Response and Survival |
title_sort | role of (f-18) fluorodeoxyglucose positron emission tomography/computed tomography in the prediction of response to neoadjuvant therapy in esophageal cancer: correlation with pathological response and survival |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348503/ https://www.ncbi.nlm.nih.gov/pubmed/37456192 http://dx.doi.org/10.4103/ijnm.ijnm_12_22 |
work_keys_str_mv | AT roblesbarbajavierj roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT lloberaaidasabate roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT cenzanocristinagamez roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT martinmarcuartujuanj roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT martineznataliaromero roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT paulesvillarmariaj roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT larranagacarlabettonica roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT ingladaannaboladeras roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT camposmarionacalvo roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT pousalbertfont roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT guzmanmaicagalan roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival AT romeramontserratcortes roleoff18fluorodeoxyglucosepositronemissiontomographycomputedtomographyinthepredictionofresponsetoneoadjuvanttherapyinesophagealcancercorrelationwithpathologicalresponseandsurvival |